Koronavirüs pandemisinde dün 952 ölümle en çok can kaybını yaşayan Almanya’nın hayat kurtaran aşılamaya başlamayı dört gözle beklediğini belirten Başbakan Angela Merkel, Avrupa İlaç Kurumu’nun (EMA) onay vermesi beklenen BioNTech-Pfizer aşısının yaratıcılarıyla görüştü.
Almanya merkezli biyoteknoloji şirketi BioNTech’in Türkiye kökenli kurucuları ve aşısının mimarları olan Dr. Özlem Türeci ve Prof. Dr. Uğur Şahin’le vídeo konferans yoluyla konuşan Başbakan Angela Merkel, çifti kutlayarak Almanya’nın böyle araştırmacılara sahip olduğu için gurur duyduğunu söyledi.
Chancellor Angela Merkel praised the accomplishments of BioNTech, the German firm behind the first coronavirus vaccine to get regulatory approval in western countries.
"You didn't throw in the towel. You believed in your research," she said.https://t.co/kBWCgXom6i
— DW News (@dwnews) December 17, 2020
Prof. Dr. Uğur Şahin LinkedIn ;
Today, Özlem and I had the honor of speaking with German Chancellor Angela Merkel, the Federal Minister of Health Jens Spahn and the Federal Minister of Education and Research Anja Karliczek. It was a great opportunity to discuss project Lightspeed and highlight the amazing work of the entire #TeamBioNTech.
Eşsiz Bilim insanları; Dr. Özlem Türeci ve Prof. Dr. Uğur Şahin
We left the conversation feeling even more inspired. Prior to a decision on approval of our #COVID19 vaccine by the European Medicines Agency (EMA) next week we shared our goal to make the vaccine widely available to help contain this pandemic. It was a special moment for all of us when the first people were vaccinated in the U.K. for the first time outside of the trials last week. We’re thrilled that more than 140.000 people have received our vaccine in the U.K. alone.
We also discussed the tremendous importance of long-term research funding, international partnerships and our collaboration with Pfizer, the power of perseverance, and our pioneering scientific spirit. This spirit is what drove us to research mRNA vaccines and other types of immunotherapies for the past two decades. Without the continued encouragement of those who believed in us and in novel technologies – and without our team of colleagues from more than 60 nations – there would be no #mRNA vaccine.
